IDT.ASX: FY26 Appendix 4E and Annual Report

FY26 Appendix 4E and Annual Report

Stock	IDT Australia Ltd (IDT.ASX)
Release Time	20 Aug 2026, 10:35 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

IDT Australia Ltd FY26 Results and Strategic Reset

Key Points

Revenue from ordinary activities increased by 3.4% to $20,534
Loss from ordinary activities decreased by 66.3% to $(2,717)
Strategic reset focused on higher-margin services and cost optimization
EBITDA improved by over 85% and revenue from core verticals grew by 16.5%
Set a three-year aspiration to reach $50 million in annual revenue by FY29

Full Summary

IDT Australia Ltd's FY26 results show a 3.4% increase in revenue to $20,534, with a significant 66.3% decrease in loss to $(2,717). The company implemented a strategic reset focusing on higher-margin CDMO services, operating leverage, and financial discipline. This resulted in an 85% improvement in EBITDA and a 16.5% growth in revenue from core verticals. The company also achieved better-than-expected annualised savings of $2.5 million. IDT Australia Ltd aims to reach $50 million in annual revenue by FY29, driven by expanding global client relationships and investing in capabilities to meet unmet demand for advanced therapeutics.

Guidance

EBITDA improved by over 85%, revenue from core verticals grew by 16.5%

Outlook

IDT Australia Ltd aims to reach $50 million in annual revenue by FY29, driven by expanding global client relationships and investing in capabilities to meet unmet demand for advanced therapeutics.